Insider Buying at Enact Holdings Signals Confidence in the Mortgage‑Insurance Play Mitchell Hardin Dean, Enact’s EVP, CFO and Treasurer, purchased 7,095 common shares on February 9, 2026, increasing his stake to 111,470 shares. The trade followed a sale of 2,172 shares the same day to satisfy tax withholding on vested Restricted Stock Units (RSUs). The purchase price—$43.54 per share—was only marginally above the 52‑week high and reflected a 0.02 % rise in the stock price, a modest but consistent uptick in Enact’s valuation.
What This Means for Investors Dean’s action is a vote of confidence that aligns with the company’s steady upward trajectory: the share price closed at $42.52, up 9.81 % monthly and 29.97 % yearly, while the P/E sits comfortably at 9.39—well below industry averages for mortgage‑insurance firms. With a market cap of $6.12 billion and a 52‑week range of $31.28 to $44.80, the stock is trading near the upper end of its range, suggesting limited room for a sharp rebound but a solid floor for further upside if Enact can capitalize on rising mortgage rates and the associated insurance premium demand. The insider buying, coupled with a high social‑media buzz (198 %) and neutral sentiment (+4), indicates that market participants are watching closely but remain cautiously optimistic.
Dean’s Insider‑Transaction Pattern Across the past year, Dean has consistently acquired RSUs rather than common stock, buying 38, 67, 81 shares in December 2025 and similar amounts in September. His most recent purchase of 7,095 shares marks the largest common‑stock transaction on record for him, suggesting a shift from deferred equity to liquid holdings. This pattern signals a willingness to lock in gains and a belief that Enact’s fundamentals will continue to support its stock price. Unlike other executives, Dean has not sold any common shares since the February 2026 trade, reinforcing a long‑term commitment to the company’s strategy.
Comparative Insider Activity Other top executives—Stolove, Gould, Gupta, Derstine, and McMullen—each completed three transactions on the same day, primarily buying and selling common shares and RSUs in roughly equal amounts. Dean’s single purchase is therefore the most concentrated activity among senior management, underscoring his personal conviction. The broader insider activity suggests a collective endorsement of Enact’s trajectory, with no single executive taking a contrarian stance.
Outlook for Enact Holdings Enact’s mortgage‑insurance business remains a niche but stable revenue stream, and its subsidiaries’ performance has not been flagged by recent corporate actions. With the U.S. mortgage market poised to grow as rates climb, Enact’s underwriting and risk‑management capabilities could translate into higher premiums and improved profitability. Investors should monitor the company’s quarterly earnings for any signs of margin compression and watch for further insider activity, which has historically presaged strategic shifts or significant corporate developments. In the near term, Dean’s purchase signals a bullish stance that could buoy the stock, while the broader insider consensus suggests a sustained endorsement of Enact’s long‑term strategy.
| Date | Owner | Transaction Type | Shares | Price per Share | Security |
|---|---|---|---|---|---|
| 2026-02-09 | Mitchell Hardin Dean (EVP, CFO and Treasurer) | Buy | 7,095.00 | 0.00 | Common Stock |
| 2026-02-09 | Mitchell Hardin Dean (EVP, CFO and Treasurer) | Sell | 2,172.00 | 42.39 | Common Stock |
| 2026-02-09 | Mitchell Hardin Dean (EVP, CFO and Treasurer) | Sell | 7,095.00 | N/A | Restricted Stock Units |
| 2026-02-09 | Stolove Evan (EVP, Gen. Counsel & Secretary) | Buy | 3,170.00 | 0.00 | Common Stock |
| 2026-02-09 | Stolove Evan (EVP, Gen. Counsel & Secretary) | Sell | 1,070.00 | 42.39 | Common Stock |
| 2026-02-09 | Stolove Evan (EVP, Gen. Counsel & Secretary) | Sell | 3,170.00 | N/A | Restricted Stock Units |
| 2026-02-09 | Gould Brian (EVP & Chief Operations Officer) | Buy | 2,609.00 | 0.00 | Common Stock |
| 2026-02-09 | Gould Brian (EVP & Chief Operations Officer) | Sell | 881.00 | 42.39 | Common Stock |
| 2026-02-09 | Gould Brian (EVP & Chief Operations Officer) | Sell | 2,609.00 | N/A | Restricted Stock Units |
| 2026-02-09 | Gupta Rohit (President and CEO) | Buy | 31,762.00 | 0.00 | Common Stock |
| 2026-02-09 | Gupta Rohit (President and CEO) | Sell | 10,348.00 | 42.39 | Common Stock |
| 2026-02-09 | Gupta Rohit (President and CEO) | Sell | 31,762.00 | N/A | Restricted Stock Units |
| 2026-02-09 | Derstine Michael (EVP and Chief Risk Officer) | Buy | 2,981.00 | 0.00 | Common Stock |
| 2026-02-09 | Derstine Michael (EVP and Chief Risk Officer) | Sell | 1,006.00 | 42.39 | Common Stock |
| 2026-02-09 | Derstine Michael (EVP and Chief Risk Officer) | Sell | 2,981.00 | N/A | Restricted Stock Units |
| 2026-02-09 | McMullen James (Controller) | Buy | 967.00 | 0.00 | Common Stock |
| 2026-02-09 | McMullen James (Controller) | Sell | 327.00 | 42.39 | Common Stock |
| 2026-02-09 | McMullen James (Controller) | Sell | 967.00 | N/A | Restricted Stock Units |




